BARINTHUS BIOTHERAPEUTICS PLC

Analyst Reco. Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Delayed Nasdaq Other stock markets 11:36:21 2024-05-21 am EDT			5-day change	1st Jan Change
2.31 ^USD	-3.71%		-0.43%	-37.40%

May. 13	Barinthus Biotherapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 01	Barinthus Biotherapeutics plc Appoints Leon Hooftman as Chief Medical Officer, Effective June 3, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vaccitech Shares Rise After Alliance Global Partners Begins Coverage With Buy Rating	23-09-25	MT
Alliance Global Partners Initiates Coverage on Vaccitech with Buy Rating, $12 Price Target	23-09-25	MT
Morgan Stanley Downgrades Vaccitech to Equal Weight From Overweight, Cuts Price Target to $3.25 From $14	23-09-25	MT
Morgan Stanley Adjusts Price Target on Vaccitech to $14 From $15, Maintains Overweight Rating	23-08-18	MT
Morgan Stanley Adjusts Price Target on Vaccitech to $15 From $16, Maintains Overweight Rating	23-05-16	MT
HC Wainwright Adjusts Price Target on Vaccitech to $15 From $20, Maintains Buy Rating	23-03-27	MT
Possibility of US Fed's Rate Hike Pause Supports American Depositary Receipts of European Equities	23-03-23	MT
Morgan Stanley Adjusts Price Target on Vaccitech to $16 From $19, Maintains Overweight Rating	22-08-15	MT
HC Wainwright Adjusts Vaccitech's Price Target to $20 From $22, Keeps Buy Rating	22-08-11	MT
Morgan Stanley Trims Vaccitech's Price Target to $19 From $20, Maintains Overweight Rating	22-05-17	MT
HC Wainwright Adjusts Price Target on Vaccitech to $23 From $25, Maintains Buy Rating	21-12-15	MT
VACCITECH : Barclays Initiates Coverage on Vaccitech With Overweight Rating, $23 Price Target	21-05-25	MT
VACCITECH : William Blair Initiates Coverage on Vaccitech With Outperform Rating	21-05-25	MT
VACCITECH : Morgan Stanley Starts Vaccitech at Overweight With $22 Price Target	21-05-25	MT
VACCITECH : Jefferies Starts Vaccitech at Buy With $28 Price Target	21-05-25	MT
VACCITECH : HC Wainwright Starts Vaccitech at Buy With $25 Price Target	21-05-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW